Table 1.
Clinical and Laboratory Characteristics of the Participants
| Variables | Prostate cancer | Benign prostate hyperplasia | p-value |
|---|---|---|---|
| Number | 100 | 108 | |
| Age (years) | 69.7 (8.1) | 70.2 (5.4) | 0.618 |
| BMI (kg/m2) | 23.6 (3.2) | 23.2 (2.9) | 0.326 |
| Current smoker (n, %) | 10 (10.0) | 9 (8.3) | 0.677 |
| FPG (mmol/L) | 5.15 (4.82-5.86) | 5.04 (4.83-5.37) | 0.273 |
| WBC (×109/L) | 6.87 (2.37) | 6.70 (1.41) | 0.527 |
| Haemoglobin (g/dl) | 133.7 (16.6) | 139.3 (15.6) | 0.014 |
| Platelet (×109/L) | 214.6 (65.3) | 215.7 (63.6) | 0.898 |
| MPV (fL) | 8.5 (1.6) | 9.9 (1.6) | < 0.001 |
| PDW (%) | 16.7 (1.7) | 17.8 (1.3) | < 0.001 |
| PSA (ng/ml) | 65.0 (22.0–100.0) | 10.0 (5.0–14.0) | < 0.001 |
Data are presented as means (SD) or median (interquartile range) or percentage; BMI, body mass index; FPG, fasting plasma glucose; PSA, prostate specific antigen; WBC, white blood cells; MPV, mean platelet volume; PDW, platelet distribution width.